LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 111 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $67,326 | -5.8% | 29,400 | 0.0% | 0.00% | – |
| Q1 2023 | $71,442 | +27.2% | 29,400 | 0.0% | 0.00% | – |
| Q4 2022 | $56,154 | -20.9% | 29,400 | 0.0% | 0.00% | – |
| Q3 2022 | $71,000 | +29.1% | 29,400 | 0.0% | 0.00% | – |
| Q2 2022 | $55,000 | -9.8% | 29,400 | +0.0% | 0.00% | – |
| Q1 2022 | $61,000 | -47.4% | 29,390 | 0.0% | 0.00% | – |
| Q4 2021 | $116,000 | -17.7% | 29,390 | +0.6% | 0.00% | – |
| Q3 2021 | $141,000 | +5.2% | 29,214 | 0.0% | 0.00% | – |
| Q2 2021 | $134,000 | -20.7% | 29,214 | +1.3% | 0.00% | – |
| Q1 2021 | $169,000 | +70.7% | 28,832 | 0.0% | 0.00% | – |
| Q4 2020 | $99,000 | +135.7% | 28,832 | 0.0% | 0.00% | – |
| Q3 2020 | $42,000 | -27.6% | 28,832 | 0.0% | 0.00% | – |
| Q2 2020 | $58,000 | +3.6% | 28,832 | 0.0% | 0.00% | – |
| Q1 2020 | $56,000 | -53.7% | 28,832 | -0.8% | 0.00% | – |
| Q4 2019 | $121,000 | +39.1% | 29,052 | 0.0% | 0.00% | – |
| Q3 2019 | $87,000 | -52.5% | 29,052 | 0.0% | 0.00% | – |
| Q2 2019 | $183,000 | +13.0% | 29,052 | 0.0% | 0.00% | – |
| Q1 2019 | $162,000 | -16.1% | 29,052 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $193,000 | -37.7% | 29,052 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $310,000 | -11.2% | 29,052 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $349,000 | +43.0% | 29,052 | +2.2% | 0.00% | 0.0% |
| Q1 2018 | $244,000 | -13.2% | 28,432 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $281,000 | -19.5% | 28,432 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $349,000 | -25.4% | 28,432 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $468,000 | +14.7% | 28,432 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $408,000 | +3.8% | 28,432 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $393,000 | -23.5% | 28,432 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $514,000 | +26.6% | 28,432 | +0.5% | 0.00% | +100.0% |
| Q2 2016 | $406,000 | +38.6% | 28,292 | +15.5% | 0.00% | 0.0% |
| Q1 2016 | $293,000 | -10.1% | 24,498 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $326,000 | +30.4% | 24,498 | +5.3% | 0.00% | 0.0% |
| Q3 2015 | $250,000 | +34.4% | 23,266 | +0.9% | 0.00% | 0.0% |
| Q2 2015 | $186,000 | – | 23,056 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |